Cancer Health Treatment Update Liver Cancer Risk Doesn’t End With Successful Hepatitis C Treatment People who developed hepatocellular carcinoma after being cured of HCV had cirrhosis and worse liver function. Uncertainty Around Tests That Screen for Many Cancers Imagine a blood test that could detect multiple types of early stage cancer. As they’re being developed, questions and concerns arise. Combo Therapy Extends Lives of Those With Prostate Cancer People with prostate cancer who received hormone therapy plus pelvic lymph node treatment experienced an average five-year survival of 87%. Mindfulness-Based Approach Addresses Sexual Health Concerns After Cancer Treatment The virtual intervention was deemed appropriate and involved an acceptable time commitment. Advertisement Long COVID Symptoms Are Often Overlooked in Seniors The higher rate of post-COVID symptoms in older adults is likely due to a higher incidence of chronic disease and physical vulnerability. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2022 Check out our latest print edition! Newsfeed Early Days of COVID-19 Brought Increased Anxiety for Some Cancer Survivors Which Cancer Patients Benefited the Most from Medicaid Expansion? New Interactive Map of Oncology Puts COVID-19, Equity Data Into Perspective R.I.P. Urvashi Vaid, LGBTQ and AIDS Activist, Attorney and Leader Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia Newsfeed Early Days of COVID-19 Brought Increased Anxiety for Some Cancer Survivors Which Cancer Patients Benefited the Most from Medicaid Expansion? New Interactive Map of Oncology Puts COVID-19, Equity Data Into Perspective R.I.P. Urvashi Vaid, LGBTQ and AIDS Activist, Attorney and Leader Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: